Boyarko, B., Podvin, S., Greenberg, B., Arnold, S., Juanes, A. M., van der Kant, R., . . . Hook, V. (2024). Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics. ACS Pharmacology & Translational Science, 7(10), 2924-2935. https://doi.org/10.1021/acsptsci.4c00229
Chicago-referens (17:e uppl.)Boyarko, Ben, et al. "Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics." ACS Pharmacology & Translational Science 7, no. 10 (2024): 2924-2935. https://doi.org/10.1021/acsptsci.4c00229.
MLA-referens (9:e uppl.)Boyarko, Ben, et al. "Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics." ACS Pharmacology & Translational Science, vol. 7, no. 10, 2024, pp. 2924-2935, https://doi.org/10.1021/acsptsci.4c00229.
